Equity Profile

SOLV

Solventum Corporation

Health CareHealth Care Supplies$13.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Solventum Corporation operates in the health care supplies sector, providing essential products that support medical professionals and patients. With a market cap of $13 billion, the company plays a crucial role in the health care industry, particularly as demand for medical supplies continues to grow amid ongoing health challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key measure of profitability and will indicate how well the company is managing its costs and generating income.

Expected to be around $1.50.

Revenue Growth

Revenue growth is critical for assessing the company’s ability to expand its market share and meet demand.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1-2026, Solventum reported an EPS of $1.48, beating estimates by 9.39%. The stock reacted positively, gaining 2.37% the following day.

Management Promises & Guidance

Continued focus on product innovation.
Commitment to improving supply chain efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Solventum's upcoming earnings, given its strong track record of beating EPS estimates.

Bull Case

If Solventum continues its trend of beating EPS estimates, it could see significant stock appreciation as investor confidence grows.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.50.

EPS is a key measure of profitability and will indicate how well the company is managing its costs and generating income.

Revenue Growth

Not available.

Revenue growth is critical for assessing the company’s ability to expand its market share and meet demand.

Gross Margin

Not available.

Gross margin reflects the efficiency of production and pricing strategy, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS figure be this quarter?

Given Solventum's history of beating EPS estimates, this number will be critical in shaping investor sentiment.

How is the company addressing supply chain challenges?

Supply chain efficiency is vital for maintaining product availability and profitability, especially in the health care sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to innovate and manage costs effectively, leading to stronger-than-expected EPS.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Recent trends in health care demand suggest a more favorable environment for growth than anticipated.

Key Risk

If EPS comes in below $1.35, it could undermine the positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Solventum's ability to maintain profitability while navigating supply chain issues.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case.

Bear Confirmed If

An EPS below $1.35 would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14% on the first day.

In-Line / Cautious

If results are in line but management is cautious, the stock may react neutrally, reflecting uncertainty.

Miss

A miss could lead to a decline, with historical data suggesting a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches.
2Insights into supply chain management and cost control.
3Guidance on revenue expectations for the next quarter.
4Comments on market expansion efforts.
5Management's outlook on industry trends.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key measure of profitability and will indicate how well the company is managing its costs and generating income.

Expected to be around $1.50.

Revenue Growth

Revenue growth is critical for assessing the company’s ability to expand its market share and meet demand.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1-2026, Solventum reported an EPS of $1.48, beating estimates by 9.39%. The stock reacted positively, gaining 2.37% the following day.

Management Promises & Guidance

Continued focus on product innovation.
Commitment to improving supply chain efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Solventum's upcoming earnings, given its strong track record of beating EPS estimates.

Bull Case

If Solventum continues its trend of beating EPS estimates, it could see significant stock appreciation as investor confidence grows.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.50.

EPS is a key measure of profitability and will indicate how well the company is managing its costs and generating income.

Revenue Growth

Not available.

Revenue growth is critical for assessing the company’s ability to expand its market share and meet demand.

Gross Margin

Not available.

Gross margin reflects the efficiency of production and pricing strategy, which is vital for maintaining profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS figure be this quarter?

Given Solventum's history of beating EPS estimates, this number will be critical in shaping investor sentiment.

How is the company addressing supply chain challenges?

Supply chain efficiency is vital for maintaining product availability and profitability, especially in the health care sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to innovate and manage costs effectively, leading to stronger-than-expected EPS.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Recent trends in health care demand suggest a more favorable environment for growth than anticipated.

Key Risk

If EPS comes in below $1.35, it could undermine the positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Solventum's ability to maintain profitability while navigating supply chain issues.

Bull Confirmed If

An EPS of $1.50 or higher would confirm the bull case.

Bear Confirmed If

An EPS below $1.35 would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14% on the first day.

In-Line / Cautious

If results are in line but management is cautious, the stock may react neutrally, reflecting uncertainty.

Miss

A miss could lead to a decline, with historical data suggesting a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches.
2Insights into supply chain management and cost control.
3Guidance on revenue expectations for the next quarter.
4Comments on market expansion efforts.
5Management's outlook on industry trends.